Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538652 · ClinicalTrials.gov registry record · NA
Just-In-Time Adaptive Interventions for Addictive Behaviors
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03538652: Clinical Trial NA study, sponsored by National Institute on Drug Abuse (NIDA).
NCT03538652 is a NA study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03538652, a NA study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Background: Many smartphone apps intend to help people with addictions. But not enough is known about how they should work. Researchers want to study an app that gives people the advice they need, just when they need it. This is a Just-In-Time Adaptive Intervention (JITAI). To create a good JITAI, researchers need to know what approaches work best at different moments. Objective: To develop ways to treat addiction with a smartphone app. Eligibility: Adults ages 18-75 who use heroin or other opioids Design: Participants will be screened in another protocol. Participants will visit a Baltimore clinic 3 days a week to give urine and breath samples. Some participants will get their treatment at this clinic. Participants will answer questions about their personality and stress. Participants will randomly be assigned to the JITAI group or a comparison group. Participants will have a training session on using the smartphone app. JITAI participants will also watch a video about the written messages they will see in the app. Weeks 3-10: Participants will carry a smartphone. Four times a day, it will beep and ask questions. These will be about the participants' activities and mood. The JITAI group will see a short message after. The message is meant to be helpful. For the first 16 evenings, JITAI participants will get more information on the phone. Answers to the app's questions will be transferred automatically from the smartphone to secure computers at the NIH. During the last week, participants can choose the kind of messages they see. Week 11: participants will return the smartphone and answer questions. Weeks 12-16, participants who are getting their medicine from the research clinic will be encouraged to transfer to other clinics. Otherwise, they will have their dose slowly reduced to zero.
Primary Outcome
Change in opioid craving within 20 minutes from receiving app messages. Participants designates four one-hour time bands within their typical waking hours, covering morning through late evening. During each of those time bands, the app will push a pair of assessments, given 20 minutes apart. Pre and post assessment ratings will be done using rating scale on the app from 0 to 100 ("0 = not at all" to "100- as much as possible"). Higher number indicates more opioid craving. Participants will compl
Interventions
- OTHER No intervention
- BEHAVIORAL Acceptance and commitment therapy (ACT)
- BEHAVIORAL Cognitive-behavioral therapy (CBT)
- OTHER Formative Interviews (not an intervention)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
Why NCT03538652 stopped before completion
NCT03538652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which No intervention is the first listed.
NCT03538652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03538652 about?
NCT03538652 is a clinical study titled "Just-In-Time Adaptive Interventions for Addictive Behaviors". Background: Many smartphone apps intend to help people with addictions. But not enough is known about how they should work. Researchers want to study an app that gives people the advice they need, just when they need it. This is a Just-In-Time Adaptive Intervention (JITAI). To create a good JITAI, ...
What is the current status of trial NCT03538652?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2020-02-19. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03538652?
The interventions under investigation include: No intervention (OTHER), Acceptance and commitment therapy (ACT) (BEHAVIORAL), Cognitive-behavioral therapy (CBT) (BEHAVIORAL), Formative Interviews (not an intervention) (OTHER).
Who is sponsoring clinical trial NCT03538652?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03538652's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI